Lucas Ward's Stock Ratings

Ascendiant Capital Analyst

Lucas Ward is an analyst at Ascendiant Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/27/2024

Overall Average Return

-58.4%

Smart Score

14%

Overall Average Return Percentile

2nd

Number of Ratings

7
Buy NowGet Alert
07/29/2024VMARBuy Now
Vision Marine
$0.42378.35%$2.5 → $2MaintainsBuyGet Alert
07/29/2024ACONBuy Now
Aclarion
$0.33389.3% → $1.6Initiates → BuyGet Alert
04/22/2024CYTHBuy Now
Cyclo Therapeutics
$1.3395.49% → $2.6Initiates → BuyGet Alert
02/26/2024LIQTBuy Now
LiqTech Intl
$2.11144.08% → $5.15Initiates → BuyGet Alert
10/30/2023VMARBuy Now
Vision Marine
$0.42976.3% → $4.5Initiates → BuyGet Alert
10/02/2023SXTPBuy Now
60 Degrees
$0.191176.6% → $2.4Initiates → BuyGet Alert
03/06/2023PIXYBuy Now
ShiftPixy
$1.67259.28% → $144Initiates → BuyGet Alert

Recent Analyst Stock Rating News

MA City Council Unanimously Decriminalizes Magic Mushrooms, Sixth In State So Far
The Salem City Council unanimously passed a measure decriminalizing adult use of psilocybin mushrooms on Thursday, May 11. 
Lobbyist Crowdfunding Group, CrowdLobby, Launches Campaign For Good Samaritan Bill Education In New York Alongside Cannabis Industry Professionals
CrowdLobby, a non-partisan crowdfunding organization, is proud to relaunch its platform under its new URL: www.crowdlobby.com, with two campaigns introduced to crowd fund public lobbyist efforts.
This Week's Cannabis News: SAFE Banking Act In The Senate, Greenlane's IPO, B-Real, Canopy Growth And More
UPDATE: Goldman Names 266 Managing Directors
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free